- The decision
- Leadership had committed to growing an established brand several times over. Which growth levers, including new indications, new geographies and digital health partnerships, could credibly close a gap of several hundred million dollars?
- What made it hard
- The target came before the evidence. Promotional support had been reduced, a similar competitor product was moving toward approval, and digital health companies were proposing partnerships faster than the team could evaluate them.
- Our approach
- We sized the incremental revenue opportunity for each adjacent indication and tracked launch readiness across multiple markets. We built a weighted assessment framework to evaluate digital health partners on clinical evidence, user base, data value and commercial readiness, and translated the findings into a prioritized investment plan.
- What leadership gained
- A new revenue opportunity of over $300 million a year from a new indication. Visibility into well over $500 million in revenue at risk if a pending product launch did not proceed, in time to inform the funding decision. A budget directed to the growth levers most likely to close the gap, with digital health partners selected on evidence rather than on the strength of their pitch.
Services
Growth and Portfolio Decisions
Talon Group Consulting advises life science leaders on where to compete and what to fund. We help leaders decide which markets, indications, and patient segments deserve investment, how a portfolio should be positioned, and whether a business case will hold up in front of an investment committee. Digital, data, and AI options are tested inside that business case from the start, including whether they belong in it at all. Technology is a deliberate lever here, not a default answer.
Common pressures
What leaders tell us they are facing
- Difficulty identifying which markets, indications, or patient segments represent the highest-value investment opportunities
- Uncertainty about whether digital, data, or AI offerings change the commercial model or only add cost
- Disconnect between R&D pipeline potential and commercial readiness across functions and geographies
- No agreed way to compare build, buy, or partner options, or to sequence the portfolio
- Business cases for new indications, geographies, or digital offerings that need to hold up under internal scrutiny
- Market data spread across functions, so leaders debate different versions of the same opportunity
What you receive
Outputs built for the decision
Each output is an input to the decision in front of you, not a standalone report.
Opportunity assessment
The opportunity, evidence, and assumptions behind a specific market or portfolio decision, assessed as an input to that decision.
Launch and portfolio roadmaps
Phased plans with milestones, investment requirements, and launch sequencing. Digital and partnership elements are included where the business case supports them.
Market prioritization models
Evidence-based prioritization frameworks that rank opportunities by revenue potential, strategic fit, and execution feasibility to sequence investments.
Strategic recommendations
Recommendations on what to fund, reshape, stop, or sequence across the portfolio, with the financial logic an investment committee will expect to see.
Risk assessments
Market, regulatory, and operational risks, with the mitigations and decision points each one needs.
Client success
Testing an Aggressive Growth Target Before Funding It
Top-10 global biopharma, Specialty Franchise
Other services
02
Operating Model and Investment Priorities
For decisions about how functions are organized and governed, and which investments the strategy depends on. Talon Group Consulting sets out what to fund, stop, or sequence, and in what order.
03Partnership and Collaboration Decisions
For decisions about whether and how to partner, and which pilots deserve further investment. Talon Group Consulting tests each option and defines what it must prove before it scales.
Facing a consequential strategy decision?
Bring the decision in front of you. We will help you frame it, test it and decide where technology belongs in the answer.